BTL Aesthetics debuts EMFACE Periorbital

Kate Byng-Hall on January 27, 2025

Aesthetic device company BTL Aesthetics has launched EMFACE Periorbital to target the under eyes.

The company explains that the device uses needle-free muscle stimulation to strengthen the lower part of the orbicularis oculi muscles, tackling eye bags, dark circles and crow’s feet. The technology also promotes lymphatic drainage to prevent fluid stagnation, according to BTL Aesthetics.

Zbyněk Pišťák, regional director at BTL Aesthetics, said, “We’re thrilled to introduce the new EMFACE Periorbital Applicators. Last year’s EMFACE Submentum launch drove a 40% increase in device utilisation, so the new Periorbital Applicators present an exciting opportunity for our partners to expand offerings and meet growing demand for advanced non-invasive treatments.”

Advertorial: Facial Muscle Modulation: The Missing Piece in the Injectable Puzzle

Kate Byng-Hall on October 14, 2024

BTL Aesthetics shares the natural lifting effects that can be achieved with EMFACEInjectables have emerged as the most widely adopted aesthetic solution worldwide, with millions of procedures performed each year. This popularity is driven primarily by the efficacy of neuromodulators …

To access this post, you must purchase Aesthetics Journal Membership – Annual Elite Membership, Aesthetics Journal Membership – Annual Enhanced Membership or Aesthetics Journal Membership – Basic Membership.

BTL Aesthetics launches new treatment platform EXION

Ellie Holden on February 23, 2024

Aesthetic device company BTL Aesthetics has debuted its new device EXION at a press launch event in London. At the breakfast event, members of the press were invited to network, witness live device demonstrations and hear more about EXION.

The company explains that the device is a 4-in-1 platform, designed to treat up to 23 areas of the body. The device includes Face, Body, Fractional RF and Emfemme 360 handpieces to address multiple aesthetic concerns. During the event, Dr Yael Halaas explained that EXION Face uses a patented combination of radiofrequency and targeted ultrasound to promote collagen and elastin synthesis, as well as natural production of hyaluronic acid. A study by BTL Aesthetics has shown that the handpiece can lead to a 224% increase in hyaluronic acid in the skin.

Dr Tamsin Lewis and Davinia Taylor also joined the panel at the event to discuss the merits of a biohacking approach to aesthetics and wellness.

Tim Taylor, managing director of BTL UK, said, “With EXION, our partners can create a bespoke treatment plan across face, body and intimate health that is tailored precisely to each patient’s unique needs.” 

Visit BTL Aesthetics on stand L11 at ACE 2024 at the Business Design Centre, London on March 15-16. Register for free by clicking here.